ZTEK Key Statistics, Chart & Performance
The current stock price of ZTEK is 0.66 USD. In the past month the price decreased by -18.01%. In the past year, price decreased by -23.26%.
ZTEK Latest News, Press Relases and Analysis
ZTEK Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.74 | 16.21B | ||
| SOLV | SOLVENTUM CORP | 13.79 | 14.20B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.83 | 11.68B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.23 | 5.12B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.17 | 4.41B | ||
| HAE | HAEMONETICS CORP/MASS | 16.75 | 3.76B | ||
| ICUI | ICU MEDICAL INC | 18.6 | 3.65B | ||
| XRAY | DENTSPLY SIRONA INC | 7.22 | 2.27B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.24 | 1.68B | ||
| NEOG | NEOGEN CORP | 22.83 | 1.49B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.17B | ||
| EMBC | EMBECTA CORP | 4.02 | 698.02M |
Related stock screener links
About ZTEK
Company Profile
Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
Company Info
ZENTEK LTD
24 Corporate Ct
Guelph ONTARIO CA
Employees: 17
Phone: 18447309822
ZENTEK LTD / ZTEK FAQ
Can you describe the business of ZENTEK LTD?
Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
What is the stock price of ZENTEK LTD today?
The current stock price of ZTEK is 0.66 USD. The price decreased by -5.85% in the last trading session.
Does ZTEK stock pay dividends?
ZTEK does not pay a dividend.
What is the ChartMill technical and fundamental rating of ZTEK stock?
ZTEK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the next earnings date for ZTEK stock?
ZENTEK LTD (ZTEK) will report earnings on 2026-02-11.
Can you provide the short interest for ZTEK stock?
The outstanding short interest for ZENTEK LTD (ZTEK) is 0.09% of its float.
ZTEK Technical Analysis
ZTEK Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ZTEK. ZTEK may be in some trouble as it scores bad on both profitability and health.
ZTEK Financial Highlights
Over the last trailing twelve months ZTEK reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 26.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.58% | ||
| ROE | -70.13% | ||
| Debt/Equity | 0.15 |